TDRL-551( —— )

Catalog No. M34443 CAS No. 1644626-43-6

TDRL-551 is a novel and potent replication protein A (RPA) inhibitor (IC50=18 μM) with potential anticancer activity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	223	In Stock
5MG	202	In Stock
10MG	297	In Stock
25MG	630	In Stock
50MG	986	In Stock
100MG	1609	In Stock
200MG	2167	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

TDRL-551
Note

Research use only, not for human use.
Brief Description

TDRL-551 is a novel and potent replication protein A (RPA) inhibitor (IC50=18 μM) with potential anticancer activity.
Description

TDRL-551 is a potent replication protein A (RPA) inhibitor (IC50=18 μM). TDRL-551 inhibits RPA-DNA interaction and increases the efficacy of Platinum (Pt)-based chemotherapy in lung and ovarian cancer. RPA plays essential roles in both nucleotide excision repair (NER) and homologous recombination (HR), along with its role in DNA replication and DNA damage checkpoint activation.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

Others
Research Area

——
Indication

——

Chemical Information

CAS Number

1644626-43-6
Formula Weight

591.83
Molecular Formula

C25H23ClIN3O4
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 62.5 mg/mL (105.60 mM; Ultrasonic )
SMILES

CCOc1ccc2cc(C3CC(=NN3C(=O)CCCC(O)=O)c3ccc(I)cc3)c(Cl)nc2c1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Mishra AK, et al. Chemical inhibitor targeting the replication protein A-DNA interaction increases the efficacy of Pt-based chemotherapy in lung and ovarian cancer. Biochem Pharmacol. 2015;93(1):25-33. ?

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

Product			Quantity Required*
Name *			E-mail Address *
Organization *			Phone Number
Remarks